US Bancorp’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $570K | Buy |
+100,000
| New | +$432K | ﹤0.01% | 1491 |
|
|
2025
Q4 | – | Sell |
-74
| Closed | -$243 | – | 4168 |
|
|
2025
Q3 | $243 | Buy |
+74
| New | +$209 | ﹤0.01% | 3930 |
|
|
2025
Q2 | – | Sell |
-825
| Closed | -$1.23K | – | 4284 |
|
|
2025
Q1 | $1.23K | Buy |
+825
| New | +$1.3K | ﹤0.01% | 3959 |
|
|
2022
Q3 | – | Sell |
-498
| Closed | -$1K | – | 4184 |
|
|
2022
Q2 | $1K | Hold |
498
| – | – | ﹤0.01% | 3988 |
|
|
2022
Q1 | $1K | Sell |
498
-364
| -42% | -$886 | ﹤0.01% | 3977 |
|
|
2021
Q4 | $3K | Hold |
862
| – | – | ﹤0.01% | 3820 |
|
|
2021
Q3 | $4K | Hold |
862
| – | – | ﹤0.01% | 3719 |
|
|
2021
Q2 | $6K | Sell |
862
-200
| -19% | -$1.4K | ﹤0.01% | 3579 |
|
|
2021
Q1 | $7K | Buy |
1,062
+200
| +23% | +$1.69K | ﹤0.01% | 3422 |
|
|
2020
Q4 | $9K | Hold |
862
| – | – | ﹤0.01% | 3230 |
|
|
2020
Q3 | $3K | Sell |
862
-1,000
| -54% | -$4.75K | ﹤0.01% | 3433 |
|
|
2020
Q2 | $9K | Buy |
1,862
+364
| +24% | +$1.24K | ﹤0.01% | 3133 |
|
|
2020
Q1 | $5K | Buy |
1,498
+998
| +200% | +$4.31K | ﹤0.01% | 3263 |
|
|
2019
Q4 | $3K | Buy |
+500
| New | +$2.81K | ﹤0.01% | 3412 |
|
|
2019
Q2 | – | Sell |
-974
| Closed | -$5K | – | 3655 |
|
|
2019
Q1 | $5K | Buy |
974
+849
| +679% | +$5.89K | ﹤0.01% | 3247 |
|
|
2018
Q4 | $1K | Sell |
125
-868
| -87% | -$9.73K | ﹤0.01% | 3515 |
|
|
2018
Q3 | $17K | Buy |
993
+100
| +11% | +$1.49K | ﹤0.01% | 2970 |
|
|
2018
Q2 | $12K | Hold |
893
| – | – | ﹤0.01% | 3088 |
|
|
2018
Q1 | $14K | Buy |
893
+593
| +198% | +$8.48K | ﹤0.01% | 3061 |
|
|
2017
Q4 | $3K | Sell |
300
-350
| -54% | -$5.21K | ﹤0.01% | 3418 |
|
|
2017
Q3 | $12K | Buy |
650
+450
| +225% | +$9.26K | ﹤0.01% | 3043 |
|
|
2017
Q2 | $5K | Hold |
200
| – | – | ﹤0.01% | 3227 |
|
|
2017
Q1 | $4K | Sell |
200
-2
| -1% | -$45 | ﹤0.01% | 3261 |
|
|
2016
Q4 | $5K | Buy |
+202
| New | +$5.62K | ﹤0.01% | 3190 |
|
|
2016
Q2 | – | Sell |
-431
| Closed | -$14K | – | 3613 |
|
|
2016
Q1 | $14K | Sell |
431
-48
| -10% | -$1.51K | ﹤0.01% | 2897 |
|
|
2015
Q4 | $14K | Buy |
479
+403
| +530% | +$13.6K | ﹤0.01% | 2950 |
|
|
2015
Q3 | $2K | Buy |
+76
| New | +$3.71K | ﹤0.01% | 3439 |
|
Other funds holding PGEN
PCM
DC
TCM
BCM
IAM
US Bancorp's PGEN Position: Q2 2026 in Review
US Bancorp opened a new position in Precigen (PGEN) in Q2 2026: 100,000 shares worth $570K. The stake represents ﹤0.01% of the portfolio and ranks #1491 among its holdings. This is a return to the name: US Bancorp previously reported a position in PGEN as recently as Q3 2025.
US Bancorp first reported a position in PGEN in Q3 2015 and has held it in 27 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.
- US Bancorp held 100,000 shares of Precigen worth $570K as of Q2 2026.
- Precigen was a new US Bancorp position in Q2 2026.
- Precigen made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1491 holding.
- US Bancorp first reported a position in Precigen in Q3 2015 and has held it in 27 quarters since.
- 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.